Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Stock Advisor

Get rid of guesswork, this advisor knows the winners.

Recently Viewed

Clear All

Concord Biotech IPO

Listed Listed stocks

Concord Biotech IPO Details

  • Bidding Date

    04-Aug-2023 to
    08-Aug-2023

  • Issue Size

    ₹1550.59 Cr

  • Price Band

    ₹705 to ₹741

  • Allotment date

    11-Aug-2023

  • Listing date

    18-Aug-2023

  • Lot size

    20

  • No. of shares

    2,09,25,652

  • Fresh issue/OFS

    -- / ₹1550.59 Cr

About Concord Biotech Company

No data found. Please visit the stock details page to know more about the company.

Read our in-depth analysis of the Concord Biotech Ltd IPO Here indepth analysis about ipo

Subscription Status

  • Category

    Status

  • QIBs

    67.7x

  • NIIs

    17x

  • Retail

    3.8x

  • Others

    24.5x

  • Total

    24.9x

Concord Biotech Financials

ipo banner

Recent IPOs

Name Price Band (Rs) Bidding Date
Autofurnish 41 21-May-2026 to 25-May-2026
Q-Line Biotech 326 - 343 21-May-2026 to 25-May-2026
Bio Medica Laboratories 132 - 139 21-May-2026 to 25-May-2026
Vegorama Punjabi Angithi 73 - 77 20-May-2026 to 22-May-2026
IPO MonitorIPO Monitor

FAQs for Concord Biotech IPO.

The issue size of Concord Biotech is ₹1,550.59 Cr.

Concord Biotech falls into Pharmaceuticals industry.

The Concord Biotech IPO will be listed on both NSE and BSE.

The open and close dates for the Concord Biotech are 04-Aug-2023 & 08-Aug-2023.

The price band for the Concord Biotech ipo is ₹705 to ₹741

The listing date of Concord Biotech IPO is 18-Aug-2023.

The purpose of this IPO is to enable the existing shareholders to sell their stake.

Concord Biotech total subscription ratio is 24.9X.

Key financial of the Concord Biotech are:


Concord Biotech FY-23 FY-22 FY-21
Revenue (₹ Cr) 853.17 712.93 616.94
EBIT (₹ Cr) 294.55 223.88 300.41
Proft after Tax (₹ Cr) 240.09 174.93 234.89
Debt (₹ Cr) 31.24 60.59 86.35
Net Worth (₹ Cr) 1290 1103.22 999.37
RoE (%) 18.61 15.86 23.5

Home > IPO Monitor > Concord Biotech